NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 34089-81-1
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of sodium ferric gluconate complex during breastfeeding. Ferrlecit contains 9 mg/mL of benzyl alcohol, which may enter breastmilk and be absorbed by the infant. An alternate intravenous drug with more published data available may be preferred.
Drug Levels
Maternal Levels.Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Sodium Ferric Gluconate Complex
CAS Registry Number
34089-81-1
Drug Class
- Breast Feeding
- Ferric Compounds
- Hematinics
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.[Am J Kidney Dis. 1999]Review Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.Faich G, Strobos J. Am J Kidney Dis. 1999 Mar; 33(3):464-70.
- Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.[Nanomaterials (Basel). 2017]Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.Wu M, Sun D, Tyner K, Jiang W, Rouse R. Nanomaterials (Basel). 2017 Dec 15; 7(12). Epub 2017 Dec 15.
- Sodium ferric gluconate therapy in renal transplant and renal failure patients.[Pediatr Nephrol. 2000]Sodium ferric gluconate therapy in renal transplant and renal failure patients.Yorgin PD, Belson A, Sarwal M, Alexander SR. Pediatr Nephrol. 2000 Dec; 15(3-4):171-5.
- Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.[Am J Kidney Dis. 1999]Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.Nissenson AR, Lindsay RM, Swan S, Seligman P, Strobos J. Am J Kidney Dis. 1999 Mar; 33(3):471-82.
- Review Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.[ANNA J. 1999]Review Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.Vogel S, Schweitzer S, Seiler S. ANNA J. 1999 Oct; 26(5):515-21.